Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod

por Correale, Jorge, Chiquete, Erwin, Boyko, Alexey, Beran, Roy G, Strauch, Jorge Barahona, Milojevic, Snezana, Frider, Nadina
Publicado 2016